7th annual Orphan Drugs and Rare Diseases Conference
In-Person Event
Oct 18 - 19, 2017
London, England, GB
OVERVIEW
7th annual Orphan Drugs and Rare Diseases Conference is organized by SMi Group and would be held during Oct 18 - 19, 2017 at Holiday Inn London - Kensington Forum, London, England, United Kingdom.
The target audience for this medical event for Abeona Therapeutics, Akcea Therapeutics, GW Pharmaceuticals, Vanda Pharmaceuticals.
The 7th annual Orphan Drugs and Rare Diseases conference will help connect industry professionals internationally, ensuring there is a great networking and learning opportunity to share knowledge of research, developments and issues. With topics being discussed such as Cell and Gene Therapy; Patient Recruitment and Patient-centric Research; Clinical Development, Regulatory Guidelines; Strategic Partnerships; Pricing and Reimbursement; and many more.
Conference Objectives are :
• Discussing strategic win-win collaborations to help accelerate rare disease clinical drug development, and improve relationships between drug developers and patients to consider both parties’ interests.
• Hear more about how patient engagement by integrating the patient perspective into the drug development process through patient advocacy, patient-centric research and patient groups.
• Learn about how the regulatory landscape for drug approvals is different between countries, and why it is important to keep informed about the regulations and guidelines of each region.
• Gain knowledge of different rare diseases and their unique challenges, as well as how treatment methods can be transferred to other rare diseases.
• Introducing cell and gene therapies to rare disease treatment - learn how gene therapy methods can improve the treatment of rare diseases and why it is becoming more commercially successful.
Additional details will be posted as soon as they are available.
The target audience for this medical event for Abeona Therapeutics, Akcea Therapeutics, GW Pharmaceuticals, Vanda Pharmaceuticals.
The 7th annual Orphan Drugs and Rare Diseases conference will help connect industry professionals internationally, ensuring there is a great networking and learning opportunity to share knowledge of research, developments and issues. With topics being discussed such as Cell and Gene Therapy; Patient Recruitment and Patient-centric Research; Clinical Development, Regulatory Guidelines; Strategic Partnerships; Pricing and Reimbursement; and many more.
Conference Objectives are :
• Discussing strategic win-win collaborations to help accelerate rare disease clinical drug development, and improve relationships between drug developers and patients to consider both parties’ interests.
• Hear more about how patient engagement by integrating the patient perspective into the drug development process through patient advocacy, patient-centric research and patient groups.
• Learn about how the regulatory landscape for drug approvals is different between countries, and why it is important to keep informed about the regulations and guidelines of each region.
• Gain knowledge of different rare diseases and their unique challenges, as well as how treatment methods can be transferred to other rare diseases.
• Introducing cell and gene therapies to rare disease treatment - learn how gene therapy methods can improve the treatment of rare diseases and why it is becoming more commercially successful.
Additional details will be posted as soon as they are available.
KEY DATES
18 Oct, 2017
Event Start Date
19 Oct, 2017
Event End Date
SPECIALITIES
GeneticsCell and Developmental BiologySUGGESTED HOTELS
CONFERENCE VENUE
Holiday Inn London - Kensington ForumRELATED CONFERENCES & LIVE WEBINARS
Quick Links